Stay the Course on Our “Obesity Blocker” Stock
Paul called this morning and asked me to send you this alert.
“Our ‘obesity blocker’ stock is swinging around today as investors position themselves for tomorrow’s FDA advisory committee meeting,” says Paul.
“Remember that today is the last day for you get in on this trade, as the stock is going to be shut down for trading while the advisory committee is meeting on June 17, 2014.”
“I know that some of you are worried about the volatility that you have been experiencing with this stock. You should know that this volatility is not unusual. This volatility is just trader positioning, as I’ve explained to you before.
“My research still says that our company’s device for obesity is safe and effective. And I believe that the advisory committee will also find its device to be safe and effective and will vote to recommend that the FDA approve it.”
You Must Be A Subscriber To View This Content.
If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication below and get access today!
Ray Blanco’s FDA Trader
Ray Blanco’s FDA Trader focuses on medical tech stocks with prices that move based on triggers generally unknown to the market. It is designed to alert you to breakout moves in the medical markets that could ultimately drive huge stock market gains. It’s the single best way to connect the dots that link today’s dynamic, innovative medical market.